| BSE: 512529 | Sector: Health care |
| NSE: SEQUENT | ISIN Code: INE807F01027 |
| BSE 00:00 | 22 Feb | 66.10 |
-0.65 (-0.97%) |
OPEN
67.35 |
HIGH
67.55 |
LOW
65.85 |
| NSE 00:00 | 22 Feb | 65.85 |
-0.85 (-1.27%) |
OPEN
66.90 |
HIGH
67.80 |
LOW
65.60 |
| OPEN | 67.35 |
| PREVIOUS CLOSE | 66.75 |
| VOLUME | 21892 |
| 52-Week high | 89.00 |
| 52-Week low | 42.45 |
| P/E | 188.86 |
| Mkt Cap.(Rs cr) | 1,611 |
| Buy Price | 66.10 |
| Buy Qty | 77.00 |
| Sell Price | 66.10 |
| Sell Qty | 73.00 |
Visistha Traders & Finance Ltd, has amalgamated PI Drugs & Pharmaceuticals Ltd with itself. The High court has sanctioned the Scheme of Amalgamation and the same was filed with ROC by the company on Nov 12, 2003. ...> More
| COMPANY INFORMATION | |||||||
| Chairman : | Gopakumar G Nair | ||||||
| Independent Director : | Kausalya Santhanam | ||||||
| Managing Director & CEO : | Manish Gupta | ||||||
| Independent Director : | Narendra Mairpady | ||||||
| Non Executive Director : | S Devendra | ||||||
| Non Executive Director : | K E C Raja Kumar | ||||||
| Joint Managing Director : | Sharat Narasapur | ||||||
| Company Secretary : | Krupesh Mehta | ||||||
| AUDITOR : | Deloitte Haskins & Sells | ||||||
| IND NAME : | Pharmaceuticals - Indian - Bulk Drugs | ||||||
| HOUSE NAME : | Indian Private | ||||||
| Registered office | |||||||
| 301 Dosti Pinnacle 3rd Floor, Plot E7 Road No 22 Wagle Indl,Thane,Maharashtra-400604 | |||||||
| Ph : 91-022-41114777 | |||||||
| WEBSITE : http://www.pidrugs.com | |||||||
| E-mail : pidsecretarial@yahoo.co.in | |||||||
